Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers

NCT00104715 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00104715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
October 18, 2004
Completion date
December 15, 2015
Enrollment
385 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer